바이오마커 기술 시장 규모, 점유율, 성장 분석 : 검사 유형별, 제품별, 프로파일링 기술별, 연구 분야별, 용도별, 지역별 - 업계 예측(2026년-2033년)

Global Biomarker Technologies Market size was valued at USD 37.56 Billion in 2024 and is poised to grow from USD 41.02 Billion in 2025 to USD 82.93 Billion by 2033, growing at a CAGR of 9.2% during the forecast period (2026-2033).

The global biomarker technologies market is vital for advancing healthcare by leveraging biological markers to evaluate normal and abnormal physiological processes and therapeutic responses. These biomarkers are identified using advanced techniques like polymerase chain reaction, next-generation sequencing, and immunoassays, playing a pivotal role in diagnosing conditions such as cancer, infectious diseases, and autoimmune disorders by highlighting relevant biological changes. Additionally, biomarkers facilitate early drug toxicity detection during development, supporting personalized medicine initiatives. Market growth is driven by rising disease prevalence, intensified research and development efforts, and increased use of early toxicity testing. However, challenges such as high initial investments and limited awareness may impede progress. Still, emerging economies present substantial opportunities for market expansion moving forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biomarker Technologies market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biomarker Technologies Market Segments Analysis

Global Biomarker Technologies Market is segmented by Test Type, Product, Profiling Technology, Research Area, Application and region. Based on Test Type, the market is segmented into Solid Biopsy and Liquid Biopsy. Based on Product, the market is segmented into Biomarker Identification, Validation & Development Research and Routine Biomarker-based tests. Based on Profiling Technology, the market is segmented into Immunoassay, PCR, Imaging Technologies, Mass Spectrometry, NGS, Chromatography, Cytogenetics and Other Profiling Technologies. Based on Research Area, the market is segmented into Genomics, Proteomics, Metabolomics and Other Research Areas. Based on Application, the market is segmented into Biomarker Identification, Validation & Development Research and Routine Biomarker-based tests. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biomarker Technologies Market

One of the key market drivers for the global biomarker technologies market is the increasing prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular disorders. As these conditions continue to rise, there is a heightened demand for early and accurate diagnostic tools that can identify diseases at their onset. Biomarkers play a crucial role in personalized medicine, enabling tailored therapeutic approaches that enhance treatment efficacy and improve patient outcomes. Furthermore, advancements in technology, such as genomics and proteomics, are facilitating the discovery and validation of new biomarkers, thus propelling innovation and investment in this rapidly evolving sector.

Restraints in the Global Biomarker Technologies Market

One key market restraint for the Global Biomarker Technologies Market is the high cost associated with research and development, as well as the implementation of advanced biomarker technologies. The complexities involved in biomarker discovery, validation, and the required sophisticated equipment can lead to significant financial burdens for research institutions and healthcare organizations. Additionally, the regulatory hurdles imposed by governing bodies can further delay the commercialization of innovative biomarker solutions, discouraging investment and exploration in this field. These factors contribute to a cautious approach from stakeholders, potentially hindering market growth and the widespread adoption of biomarker technologies.

Market Trends of the Global Biomarker Technologies Market

The global biomarker technologies market is witnessing a transformative shift, propelled by the increasing integration of personalized medicine into healthcare practices. As the understanding of genomics, proteomics, and molecular diagnostics advances, biomarkers are pivotal in tailoring disease management to individual patients, enhancing the precision of diagnosis, prognosis, and treatment strategies. Furthermore, there is a notable rise in the demand for non-invasive and minimally invasive testing methods, such as liquid biopsies, which are enhancing patient comfort while improving diagnostic accuracy. This convergence of innovation and patient-centric approaches is further fueling market growth and expanding the application scope of biomarker technologies.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement

Global Biomarker Technologies Market Size by Test Type & CAGR (2026-2033)

• Market Overview
• Solid Biopsy
• Liquid Biopsy

Global Biomarker Technologies Market Size by Product & CAGR (2026-2033)

• Market Overview
• Biomarker Identification, Validation & Development Research
  • Consumables
  • Instruments
  • Services
  • Software
• Routine Biomarker-based tests
  • Consumables
  • Instruments
  • Services
  • Software

Global Biomarker Technologies Market Size by Profiling Technology & CAGR (2026-2033)

• Market Overview
• Immunoassay
  • ELISA
  • Western Blot
  • Protein Microarray
• PCR
• Imaging Technologies
• Mass Spectrometry
• NGS
• Chromatography
• Cytogenetics
• Other Profiling Technologies

Global Biomarker Technologies Market Size by Research Area & CAGR (2026-2033)

• Market Overview
• Genomics
• Proteomics
• Metabolomics
  • Metabolic Flux
  • Lipidomics
  • Others
• Other Research Areas

Global Biomarker Technologies Market Size by Application & CAGR (2026-2033)

• Market Overview
• Biomarker Identification, Validation & Development Research
• Routine Biomarker-based tests

Global Biomarker Technologies Market Size & CAGR (2026-2033)

• North America (Test Type, Product, Profiling Technology, Research Area, Application)
  • US
  • Canada
• Europe (Test Type, Product, Profiling Technology, Research Area, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test Type, Product, Profiling Technology, Research Area, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test Type, Product, Profiling Technology, Research Area, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test Type, Product, Profiling Technology, Research Area, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Waters Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shimadzu Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations